Dylan J. Martini
0000-0002-0843-1222
Publication & Citation Trends
Publications
0 total
Baseline geriatric 8 (G8) screening tool predicts overall survival in metastatic urothelial carcinoma treated with immune checkpoint inhibitors
Cited by 0
Semantic Scholar
Impact of concomitant medication use on treatment outcomes in patients with RCC treated with immune checkpoint inhibitors.
Cited by 0
Semantic Scholar
The Future of Personalized Cancer Vaccines.
Cited by 11
Semantic Scholar
Non-clear cell renal cell carcinoma in the immune checkpoint era: A retrospective study on survival and treatment approaches.
Cited by 1
Semantic Scholar
Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma (aRCC) treated with immune checkpoint inhibitors (ICIs).
Cited by 0
Semantic Scholar
Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes.
Cited by 4
Semantic Scholar
Association of CD8 T cell infiltration in the tumor microenvironment with survival outcomes in patients with metastatic renal cell carcinoma (mRCC).
Cited by 0
Semantic Scholar
Association of race with clinical outcomes in patients with advanced renal cell carcinoma (aRCC) treated with immune checkpoint inhibitors (ICIs).
Cited by 0
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(51)
Renal cell carcinoma treatment
(45)
Bladder and Urothelial Cancer Treatments
(30)
Inflammatory Biomarkers in Disease Prognosis
(20)
Multiple and Secondary Primary Cancers
(15)
Affiliations
University of Vermont
Emory Healthcare
Harvard University
Emory University
University of Washington